Member Info for Cliostock

Aquae, some fair points raised there. I’m still a committed supporter of Stuart, the company and the potential within, but I do think it’s natural to view these things with a critical eye once targets and previous indications don’t come to fruition. We’re not groupies after all and I’m sure between us we have a substantial amount invested in the company.

Toyin, I think in one of SA’s interviews after the half year report RNS was released he spoke specifically about social media and dealing with influencers when talking about Danielle. However that’s not to say she won’t do a sweeping review of the business as a part of her work. I know I would be if I was in her position. We’ll have to give her time to show us what she is capable of and I’m sure you’re with me in willing her to succeed in her new role.

If we have recruited the right people, they will surely point out the obvious to the board in terms of advertising campaign and what can be done with the ad spend strategy. I understand a three person team cannot cover all these bases alone but now the team is bolstered things like Google ads, website updates etc should be happening soon. We just have to hope we’ve recruited people with initiative, which to be frank will be a challenge at the salaries offered.

I’m very keen on the prospects of SBTX as a company in general, but I too share the opinion of you guys. I think it’s certainly been the case that myself, bel, elrico and others have given high authority to the positives here and in order to be balanced and not reckless we have to give high authority to the negatives. I will likewise be watching closely and hoping for the team to consider the roller coaster that the missed forecast has inevitably sent us loyal investors on, and hoping they get us off it as soon as possible. I’m still very enthusiastic about Stuart as a CEO, I trust him, I understand how and why the forecast may have been missed. I now hope that he shows himself to be what I believe him to be. I will be bitterly disappointed if the company goes quiet and leaves us hanging in the twenties and early thirties. Stuart has strongly reiterated that there is so much going on and we need to know all about it as well as the moment this target is hit. I somewhat worry for the fortunes of investors if we are not there in the next 6 months.

One thing that stands out to me is that at the investor meet in Manchester Stuart told us about his friend that bought in at 71p. Obviously I have no idea if he is still holding but I think that is representative of how much of Stuart’s personal reputation is now on the line. He was on track to being known as a real Super-CEO and his upcoming actions will dictate if he is, or isn’t. I’m still on his side that he is a Super-CEO for now.

I’m as disappointed as the next investor about the missed forecast, and specifically about the use of the word ‘material’. But you have to hand it to Stuart, he has got out there and faced the music head on, doing interviews and doing what he can to reassure the market as much as he can, given the facts.

Surprised to see us down on the day so far. The market must really like Doug Quinn!

Elric, what do you mean by saying you think we will do well to avoid repeating OPTI history?

Whoever wrote that isn’t shy of bullishness. Let’s hope the update is in the ballpark of what is implied!

Is this a job advert you have seen Milky?

If so, it is possible that other products are not so far away. I would think it would be a stretch to keep a full time content creator busy working just on Axisbiotix once social media foundations are established and the content strategy is ticking over. Surely the board have in mind that this person would then be creating content for things such as an Acne product and/or products for other skin conditions. And of course we probably don’t know the extent of what Geoff Bell is working on alongside Axis.

**Will be released during March.

Regarding the date of the 14th, I don’t believe the company has indicated this would be the date. Last years half year report was released on the 15th March, which was a Thursday. The company has only said the report was released during March.

Good post Aquae, I will also be extremely pleased if the 1.2M sales figure comes to fruition.

Does anyone have any opinions to share on the Croda SP since December? Down from £104 to £70 in around 2 months. Don’t see any stand out reason for it. It’s almost as if they could do with releasing a groundbreaking science backed new product to disrupt the cosmetics market!

Cheers for the link Troajan. These editorials usually do produce a positive reaction reflected in the share price.

This tells me they are still busy substantiating the improved claims. I’m sure Croda want to get the product and their production line moving, after all the lions share of the liabilities AND possibly huge profits are theirs, so if it’s something that’s worth them waiting for it must be something worth us waiting for!

I think there is plenty of time for an RNS to tell us about the launch before the half year report.

Really pleased to see Tyndall upping their stake. I’m sure most committed lth’s have bought at least a few more shares whilst they have been on sale and Tyndall are no different. I’m sure our patience will be rewarded here, the blue days are coming back with a vengeance.

I think we can expect some peaks and troughs now plenty of people have had the opportunity to buy in at such a low price and some will want to take profit (far too early if you ask me). I do hope the momentum continues into some good upcoming news so we can regain a more realistic share price. As has been said a few times, nothing has changed at the company since the price was 75p!

Here’s to that blue day tomorrow Bel. Looks like we’ve got that sort of lift that we get when news is expected. I think there could be some legs in it, especially when new investors realise there is II’s recently in at 55p!

Always wise DK, I operate with the same sentiment but I have spent a lot of time and energy finding out everything there is to know about SBTX and I haven’t found out anything untoward. In fact SBTX is ran so impressively that I now don’t invent in companies I previously would have because I have become accustomed to SA and his teams standard of doing things in the more risk adverse yet still progressive way possible.